Researchers: Cannabis Will Be the Next Hot Skincare Ingredient
The beauty industry loves new ingredients — as witnessed by the use of such gems as Cochineal beetles (skin creams, lipstick, etc.), bird poop for a Geisha facial and whale vomit – or ambergris – for making perfume.
And now, according to UK-based The Future Laboratory, cannabis will be the next big ingredient of choice for the beauty industry, including skin- and hair-care products; as well as makeup and perfume.
“Growing support for legalization and an increased awareness of the potential benefits of cannabis are the driving forces behind this ingredient,” said Victoria Buchanan, trend analyst at The Future Laboratory, to The Telegraph.
Pot’s anti-aging and protective capabilities alone are enough to make it a primary ingredient in skin care, according to two dermatologists interviewed by the Huffington Post.
Lemon Kush (Hybrid)
Lemon Kush is an amazing strain known for excellent flavors, especially when grown organically. The breeder remains mysterious, but there is nothing to be questioned about these dense, frosted buds that provide a long-lasting, lung-destroying high. This bud is a cross of Master Kush and Lemon Joy, providing a potent indica-dominant effect.
Cure Your Headaches With Medical Cannabis!
Bubba OG (Indica)
Bubba OG Kush is a must-have strain, but honestly if you haven't tried it yet you probably are living under a rock or on the East Coast - in which case it's not your fault. Bred by Breeder's Choice Organization, this potent indica-dominant strain will cause you to think about devouring your entire kitchen and then some. Bubba Kush has buds that are medium-sized and tight, dark-green buds. They are also completely infested with trichromes when grown as top-shelf bud.
Doctors Using Cannabis to Treat Autism in First-of-Its-Kind Study
After seeing marijuana’s success in treating epilepsy, an Israeli pediatrician has launched a clinical trial to study the effects of medical cannabis on autistic children and adults.
According to Haaretz, Dr. Adi Eran, head of the pediatrics neurology department at Shaare Zedek Medical Center in Jerusalem, will be heading up the endeavor, which is in the process of obtaining permits from the Health Ministry. The study will reportedly involve 120 autistic individuals, male and female, aged 4 to 30, who are defined as low to medium functioning. Participants will be given cannabis oils free of THC but rich in CBD.
“Per the norm in proper clinical research, participants will be divided into two groups: the test group that actually ingests the oil, and the control subjects who will be given placebos,” Haaretz reported. “After a test period during which the effects on the patients will be recorded, treatment will be halted for a month, then the groups will be reversed—the test group will become the control group and vice versa. Again, as is typical in such research, at no point will subjects or their families know whether the patient is receiving CBD or a placebo.”
- 193,424 Views Category: Odd
- 152,376 Views Category: Fun
- 141,872 Views Category: Culture
- 104,419 Views Category: Culture
- 102,780 Views Category: Culture
- 101,767 Views Category: Fun
- 82,210 Views Category: Culture
- 80,390 Views Category: Odd
- 72,305 Views Category: Fun
- 65,677 Views Category: Fun